Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. [Phase 2]
A Phase 2 trial evaluating palbociclib in second-line treatment of advanced sarcomas with CDK4 overexpression; current status unknown.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Phase II Study of TAEST16001 in Soft Tissue Sarcoma [Phase 2]
Phase II trial update is provided for TAEST16001 in soft tissue sarcoma, with the study status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) [Phase 2]
Phase 2 trial ATLAS-IT-04 evaluating LTX-315 in combination with adoptive T-cell therapy for advanced soft tissue sarcoma has completed and …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg [Phase 2]
Phase 2 clinical trial evaluating isolated limb perfusion of melphalan with or without tumor necrosis factor for soft tissue sarcoma of the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Use of GnRHa During Chemotherapy for Fertility Protection [Phase 3]
Phase 3 trial investigating GnRHa during chemotherapy to protect fertility in cancer patients; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) [Phase 2]
Phase 2 trial update for treatment of metastatic soft tissue sarcoma (leiomyosarcoma) under FIBROSARC USA.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating YH001 plus Envafolimab with or without doxorubicin in advanced or metastatic sarcoma (including soft t…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer [Phase 2]
Phase 2 trial of ADI-PEG 20 in combination with gemcitabine and docetaxel for soft tissue sarcoma, osteosarcoma, Ewing's sarcoma, and small …
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall [NA]
Phase II trial update on preoperative proton therapy for soft-tissue sarcomas of the extremities and body wall has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating perifosine for metastatic or locally advanced soft tissue sarcoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update on anlotinib as maintenance treatment for advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: TVEC and Preop Radiation for Sarcoma (8 ml Dose) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating talimogene laherparepvec (TVEC) with preoperative radiation for soft tissue sarcoma has posted results…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial comparing durvalumab and tremelimumab versus doxorubicin in advanced/metastatic soft tissue sarcoma (completed).
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall [NA]
A completed study evaluated hypofractionated pre-operative radiation therapy for soft tissue sarcomas of the extremity and chest-wall. Resul…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating pazopanib with durvalumab for metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas [Phase 1, Phase 2]
Results from a Phase 1/2 trial evaluating high-dose intravenous ascorbate in combination with preoperative radiation for locally advanced so…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
This Phase 2 pediatric MATCH trial update reports results for tazemetostat in patients with relapsed or refractory solid tumors, non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib with toripalimab for refractory and advanced soft-tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update for surufatinib in patients with sarcoma including osteosarcoma and soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas [Phase 2]
Phase 2 multicohort trial evaluating trabectedin with low-dose radiation therapy in advanced/metastatic soft tissue sarcomas and related bon…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide [Phase 1, Phase 2]
Phase 1/2 trial of weekly trabectedin combined with metronomic cyclophosphamide in soft-tissue sarcoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas [NA]
Clinical trial update for SBRT and ART in pulmonary metastases from soft tissue sarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of doxorubicin in combination with pembrolizumab for soft tissue sarcoma has com…